Sotera Health Company
Research Sotera Health Company (SHC) on Bullrun: valuation model: 18.4% overvalued, market cap USD 5.00B, P/E 42.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSHC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal18.4% overvalued
- Market capUSD 5.00B
- P/E42.7
- Financial periodFY2025
- RevenueUSD 1.16B
- Revenue growth5.7%
- Net incomeUSD 77.95M
- Free cash flowUSD 149.18M
- Gross margin55.5%
Valuation Snapshot
Bullrun's latest valuation model marks Sotera Health Company as 18.4% overvalued; latest market cap is USD 5.00B; P/E is 42.7.
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Frequently asked questions
Is Sotera Health Company overvalued or undervalued?
Bullrun's valuation model currently marks Sotera Health Company as 18.4% overvalued.
What is Sotera Health Company's market cap?
Sotera Health Company's market capitalization is USD 5.00B.
What is Sotera Health Company's P/E ratio?
Sotera Health Company's price-to-earnings (P/E) ratio is 42.7.
What does Sotera Health Company do?
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.